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Abstract
The gut mucosa is continuously exposed to food and microbial antigens. Both enterocytes and intraepithelial
lymphocytes have a pivotal role in maintaining the integrity of intestinal mucosa, as these cells guarantee a first line
of defense against pathogens and toxic molecules. Enterocytes maintain a physical barrier against microbes and
directly contribute to the gut homeostasis by sampling the luminal agents through several pattern recognition
receptors or presenting antigen to mucosa T cells. Similarly, due to a close physical contact with the intestinal
epithelial cells, the intraepithelial lymphocytes represent an important part of the gut lymphoid tissue, contrasting
the entry and spread of pathogens. An alteration of the cross-talk between intestinal epithelial cells and
intraepithelial lymphocytes might actively contribute to the development of intestinal immune disorders, as
occurring in patients with celiac disease. In genetically predisposed individuals, the gluten exposure results in a
massive production of interleukin-15, activation of intraepithelial lymphocytes, and modification of small intestinal
mucosa architecture and function. We will review the recent studies on the pathophysiology of cross-talk between
enterocytes and intraepithelial T cells, and how this interaction is crucial for intestinal integrity and homeostasis.
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Intestinal lymphoid tissue
The gut-associated lymphoid tissue (GALT) is the largest
immune compartment of the body, due to the high
cellular number and tissue dimension [1]. The GALT is
structured in both organized tissues that comprise
Peyer’s patches (PP) and mesenteric lymph nodes
(MLNs), and in diffuse lymphoid tissues, with immuno-
competent cells scattered in both the epithelium and
lamina propria of the throughout intestinal mucosa [2].
The GALT is daily in contact with a large number of
harmful and innocuous antigens. In healthy condition, it
efficaciously distinguishes between pathogenic antigens,
to which an active immune reaction is needed, and non-
pathogenic ones, such as commensal bacteria and food
antigens, to which an inflammatory reaction would be
deleterious. The GALT unresponsiveness toward innocu-
ous antigens, termed oral tolerance, is a fine balanced
and strictly regulated process, and its dysregulation is re-
sponsible for development of food allergies and chronic
inflammatory disorders [2].
The gut tropism of circulating lymphoid cells is de-
termined by selective interactions between adhesion
receptors, expressed on the surface of immune cells,
and matched ligands on endothelial cells. In the case
of T lymphocytes, these cells are selectively driven
from peripheral blood to lamina propria or epithelial
compartments, depending on the specific homing recep-
tor they express. In particular, lamina propria homing is
determined by high levels of integrin α4β7, interacting with
the ligand MadCAM-1 (mucosal vascular cell adhesion
molecule-1) on the vascular endothelium, whilst the
epithelium commitment is given by the expression of
the integrin αE(CD103)β7 recognized by E-cadherin ligand
on the basolateral surface of enterocytes [2].
Intestinal epithelium infiltrating lymphocytes:
phenotype and function
In the epithelium compartment, the GALT is constituted
by a heterogeneous population of T lymphocytes (IELs)
whose main role is to maintain immune surveillance.
Strongly influenced by several luminal factors, as soluble
antigens and microbiota, the phenotype and function of
IELs markedly change throughout the intestinal tract [3].
* Correspondence: c.gianfrani@ibp.cnr.it




© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Vitale et al. Molecular and Cellular Pediatrics  (2016) 3:20 
DOI 10.1186/s40348-016-0048-4
Whilst in the colon the IELs population is mostly com-
posed of T cell receptor (TCR) αβ+ CD4+ T cells, in the
small intestine it is mainly consisted of CD8+ T cells,
carrying the αβ or γδ TCR. In particular, in the small in-
testine, 70–80 % of IELs are CD8αβ+ cells expressing
TCRαβ+, 10–15 % are TCRαβ+ CD4+ T cells, and less
than 10 % of cells carrying TCRγδ+ (either CD8+ or
double CD8 CD4 negative cells) [3]. The TCRαβ+
CD8αβ+ IELs may express either the inhibitory or co-
activator natural killer receptors (C-type lectins NKRs)
[3]. In the absence of biological or physical insults,
TCRαβ+ IELs have low cytolytic abilities, express inhibi-
tory CD94/NKG2A and low levels of the activating
NKG2D receptor, whilst at the same time intestinal epi-
thelial cells do not express ligands for NKRs. Under
physiological conditions, the TCRγδ+ IELs have an anti-
inflammatory role mediated by the secretion of regulatory
cytokines, as IL-10 and TGF-β. In the presence of inflam-
matory stimuli, the TCRαβ+ IELs up-regulate the activat-
ing NKRs, produce pro-inflammatory cytokines, as TNF-α
and IFN-γ, and trigger the lysis of infected enterocytes by
releasing both perforin and granzyme B and thus prevent-
ing the entry and spread of pathogens. Indeed, IELs also
participate in the epithelial healing by promoting the
intestinal epithelial cell (IEC) growth and epithelial layer
repair through the keratinocyte growth factor (KGF)
release and by removing infected cells [3].
Intestinal epithelial cells: emerging role as
non-immune inflammatory cells
The IECs form a continuous layer that covers the inside
part of the gastrointestinal tract surface. In the past,
IECs were considered essentially as non-immune cells
with a passive role of physical barrier or target of cytotoxic
immune cells. Recent studies have underlined the inflam-
matory role of IECs, in particular as non-professional
antigen-presenting cells. Because of the IECs expressing
on their surface the major histocompatibility class (MHC)
I and II molecules, as well as non-classical MHC mole-
cules (MIC A/B) whose expression increase in the pres-
ence of inflammatory stimuli, they are able to process and
to present antigens to both IELs and lamina propria T
lymphocytes. Moreover, IECs actively contribute to patho-
genic bacteria clearance and to gut homeostasis toward
the commensal bacteria, due to the surface expression of
pattern recognition receptors (PRRs), as Toll-like recep-
tors (TLRs) and nucleotide-binding oligomerization do-
mains (NODs) [4]. Depending on the intestinal tract sites,
the epithelial layer is composed of different types of IECs:
enterocytes, goblet, Paneth, and enteroendocrine cells [5].
Each cell subset shows a different morphology and
function: the enterocytes have microvilli on their apical
surface, whilst the goblet cells contain large vacuoles
and secrete mucus; both prevent pathogen invasion.
The enteroendocrine cells, scattered throughout the
epithelium, produce hormones involved in cellular
tropism, tissue repair, and enterocyte differentiation.
Interestingly, recent finding suggested that this cell
population has a direct role in the gut response to
pathogen and commensal bacteria, acting as innate sen-
sor [6]. Finally, the Paneth cells, mainly placed in the
crypts, release defensin peptides against pathogens.
Though stem cells in the crypts guarantee a continuous
and rapid renewal of the intestinal epithelia, alterations
in defensin and mucus production, due to luminal insults,
damage the integrity of mucosa barrier and may contrib-
ute to intestinal immune-mediated disorders, as inflam-
matory bowel disease (IBD) and celiac disease (CD) [7].
Enterocytes and T cells in celiac disease
Adaptive immune response to gluten in the small
intestinal mucosa of celiac patients
Celiac disease (CD) is a small intestinal disorder provoked
by a dysregulated immune response to wheat gluten and
related proteins of barley and rye. This multifactorial dis-
ease, caused by both genetic and environmental factors, is
characterized by a mild to severe enteropathy and a
humoral response to the tissue-transglutaminase autoanti-
gen. HLA class II DQ2 and DQ8 genes are the main risk
factors for CD [8] and present gluten immunogenic pep-
tides to lamina propria T lymphocytes, as documented by
several studies [9]. Following gluten stimulation, a marked
proliferation of Th1 and Th0 lymphocytes, and an in-
creased production of inflammatory cytokines, mainly
interferon-γ (IFN-γ), characterize the celiac intestinal mu-
cosa. Up to now, several peptides, derived from gliadins
(α-, ω-, and γ-gliadins) and from glutenins, have been
identified to stimulate CD4+ T cells in CD subjects [9, 10].
Remarkably, gluten-specific CD4+ T cells can be isolated
from the small intestinal biopsies of CD patients and not
from non-celiac controls, thus underlining their patho-
genic relevance [11].
Despite the pivotal role played by CD4+ T lymphocytes
in the pathogenesis of CD, recent evidences suggested the
involvement of CD8+ T cells in the inflammatory cascade
elicited by gluten. The extensive infiltration of CD8+ T
lymphocytes in the mucosa of CD patients, both in the
epithelium and lamina propria, represents a histopatho-
logical hallmark [12]. Notably, gliadin contains peptides
able to bind HLA class I molecules on the surface of
antigen-presenting cells [11]. We have found that a short
peptide of 10 amino acid length (QLIPCMDVVL), map-
ping the 123-132 region of α-gliadin stimulates CD8+ T
lymphocytes in both peripheral blood and intestinal mu-
cosa of HLA A2-positive celiac patients [13]. A further
study with organ culture of celiac mucosal explants has
demonstrated that this peptide specifically stimulates cyto-
toxic CD8+ T cells resident in the lamina propria and
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induces the apoptosis of enterocytes [14]. Interestingly,
initial findings associated the HLA class I A*01 and B*08
genes with susceptibility to celiac disease (CD), though
further analysis showed a primary association with alleles
encoding for HLA DQ2/8 molecules [15]. By using bio-
informatic algorithms for the prediction of peptides with
binding motives to surface molecules encoded by A*01
and B*08 genes, we found several sequences in all three
main gliadin families that bound to either HLA A1 or B8
molecules with high affinity. Selected peptides also
recalled IFN-γ responses in A*01+ and B*08+ CD patients
(Picascia et al. manuscript in preparation). A recent
genome-wide association study (GWAS) has highlighted
the role of B*08 gene, in strong linkage disequilibrium
with DR3-DQ2.5, as additional susceptibility factor for CD
[16]. Altogether, these findings sustain our previous data
on HLA class I-restricted T cell responses in CD and
strongly encourage further studies to dissect this, still un-
explored, pathway in CD pathogenesis.
Innate immune response to gluten in the small intestinal
mucosa of celiac patients and the role of IL-15
A consistent number of studies have demonstrated that
gliadin contains peptides, particular mapping the NH2-
terminal part of α-gliadin, able to stimulate innate
immuno-competent cells, or even to exert a direct cellu-
lar toxicity [17]. After a brief incubation with gliadin
peptide p31-43, Maiuri and co-workers reported that the
uninflamed CD mucosa up-regulated the expression of
ICAM-1, CD69, and HLA-DR markers and the density
of interleukin-15 (IL-15)-positive cells. Upon a longer
stimulation, an increased expression of CD83 on den-
dritic cells and of CD25 on T cells and macrophages was
observed. This peptide also induced intraepithelial mi-
gration of CD8+ T cells in treated CD mucosa and an
epithelial damage mainly due to enterocyte apoptosis.
Moreover, the same authors found that an early activa-
tion of the innate cells might favor the capacity of glia-
din peptides, particularly p31-43, to stimulate the
adaptive T cell response to immunodominant gliadin
epitopes [18]. IL-15 seems to have a key role as mediator
of the gliadin-elicited innate activation, as the use of spe-
cific neutralizing antibodies inhibited a great part of the
above pathways [18].
IL-15 is a pleiotropic pro-inflammatory cytokine,
member of the IL-2 family, involved in several mecha-
nisms of both immune and non-immune systems. It is
expressed on the surface of mainly monocytes, macro-
phages, dendritic and epithelial cells in response to in-
flammatory stimuli. IL-15 has numerous activities,
including anti-apoptotic function, stimulation of T cell
proliferation, generation of cytotoxic T lymphocytes, and
regulation of NK cell survival and function, as well as
the induction of immunoglobulin synthesis by B cells.
IL-15 is also an important growth and activator factor
for both IELs and IECs. In small intestinal biopsies of
healthy subjects, IL-15 protein is almost absent in the
lamina propria but expressed, though at low intensity,
on villous enterocytes. By contrast, in inflammatory con-
dition, as in active CD mucosa, IL-15 is highly expressed
by lamina propria mononuclear cells and by intestinal
epithelial cells. The overexpression of IL-15 in the epithe-
lium layer has a key role in TCR-independent expansion
and activation of IELs in CD mucosa with villous atrophy
[19]. Mention et al. reported that IL-15 was massively
expressed at the surface of IECs and it was associated with
an enhanced transcription of IFN-γ in untreated CD and
in refractory celiac sprue patients (RCS), a pathological
condition, characterized by massive intraepithelial infiltra-
tion with abnormal phenotype and unresponsive to the
gluten-free diet [20]. The increased IL-15 levels on entero-
cytes selectively promoted the growth and activation of
clonal CD103+ CD3− IELs in RCS.
Furthermore, it was demonstrated that in CD, IL-15
induced on the epithelial cells similar effects to those
elicited by gliadin, as the TFR and FAS expression in
both crypt and villous enterocytes, and the up-regulation
of Ki67 expression, a marker of cell proliferation. Over-
all, these results suggested that gluten-induced IL-15 has
a pivotal role in the epithelial layer and lamina propria
modifications in CD mucosa [21].
There is a general consensus that the mechanisms in-
volved in the villous atrophy in patients with full-blown
CD include both the intensive epithelium infiltration by
T cells and the increased expression of IL-15, and of
non-classical MHC class I molecules, as MICA and
MICB, on IECs. MICA and MICB proteins are ligands
for the activating NKG2D receptors expressed on the
surface of both TCRαβ and TCRγδ CD8+ T cells. MICs
act as cellular stress signals and their recognition by
NKG2D receptors induces several immune mechanisms,
such as cellular cytotoxicity, proliferation, and cytokine
secretion. IECs in the inflamed intestinal mucosa of CD
patients show an increased expression of non-classical
MHC class I molecules. At the same time, the IELs from
CD subjects express high levels of the activating NKG2D
and CD94/NKG2C receptors and mediate the killing of
enterocytes via NKG2D. Additionally, IL-15, by up-
regulating the NKG2D receptors, switches on the cyto-
toxic activity of IEL directed on the neighbor IECs [22].
As previously mentioned, in normal conditions, the
cross-talk between IECs and IELs mediated by NKG2D/
MIC might maintain the epithelium in a healthy condi-
tion eliminating infected cells. By contrast, in the case of
uncontrolled IL-15 production by IECs induced by glu-
ten, as in celiac intestinal mucosa, intraepithelial CD8+
T cells are converted into activated killer cells and con-
tribute to epithelial cell destruction and tissue atrophy
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through a TCR-independent NKG2D signaling pathway
[23]. A recent study by Setty and co-workers showed
that IECs from healthy subjects with a family history of
CD expressed higher levels of IL-15 and heat shock
proteins (HSPs) than controls and have ultrastructural
epithelial alterations [24]. In addition, they found that
the cytotoxic IEL from relatives of CD patients expressed
higher levels of activating NK receptors than cells from
controls, although at lower levels than patients with active
CD. By contrast, IEL from subjects with potential CD
failed to up-regulate activating NK receptors, thus sug-
gesting that the fine balance between inhibitory and acti-
vating molecules expressed by NK cells is variable in the
different forms of the CD. These results re-mark that the
innate epithelial stress is an important event to convert
IELs into active killer cells and to induce villous atrophy.
Conclusions
It is becoming clearer that epithelial layer is not only a
passive physical barrier against luminal microorganisms
and toxic molecules but has a more active role in main-
taining the intestinal mucosa integrity. Through a num-
ber of surface membrane receptors, enterocytes may act
as biosensor of microorganisms preventing their mucosal
entry. Furthermore, intestinal epithelial cells take mucosal
antigens up and act as non-professional antigen-presenting
cells, directly activating the T cell resident both in the epi-
thelium and lamina propria below. Besides the properties
mentioned above, the prominent role of enterocytes as
non-immune inflammatory cells is emerging in immune-
mediated disorders. To throughout dissect the cross-talk
between intestinal epithelial cells and lymphocytes of both
epithelium and lamina propria compartments, it is needful
to understand the physiology of intestinal mucosa, as well
as the development of intestinal inflammatory cascade
occurring in common, and worldwide growing, intes-
tinal disorders, as CD and IBD.
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